Sam Bankman-Fried’s fourth day on the stand did not go well

View in Browser October 31, 2023 Dow 33,052.87 0.38% S&P 500 4,193.80 0.65% NASDAQ 12,851.24 0.48% Last updated October 31 at 4:59 PM ET     Sam Bankman-Fried's fourth day on the stand did not go well Sam Bankman-Fried has stepped down from the stand, after four days of testimony in his criminal fraud trial.    Read full article   Bud Light sales keep sinking Bud Light continues to be a drag on Anheuser-Busch InBev's bottom line in the United States, but the world's biggest brewer saw its global revenue rise and beating expectations.    Read full article   Analysis: It's a spooky Halloween for markets. Here's why Markets soared higher on Monday as the US government said its borrowing needs would decline in the final three months of the year from the prior quarter.    Read full article   Carlsberg says Moscow stole its Russian business Carlsberg has cut all ties with its Russian business and refuses to enter a deal with Russia's government that would make Moscow's seizure of the assets look legitimate, the brewer's new CEO said Tuesday.    Read full article   Stellantis takes $3 billion revenue hit from autoworker strikes Historic strikes by autoworkers in North America have cost Stellantis €3 billion ($3.2 billion) in lost revenue, the maker of Chrysler and Jeep said Tuesday.    Read full article   Biden administration wants to kill 'junk' fees in retirement investments and advice As part of its ongoing effort to make it easier for Americans to amass retirement savings and protect consumers from having to pay "junk" fees, the Biden Administration on Tuesday will propose a rule that would require any financial adviser, broker or insurance agent who sells retirement investments and advice to only do so in the best interest of their clients, not their own.    Read full article   Today's movers SPRC 5.62 64.81% SciSparc Ltd. TSBX 3.56 44.13% Turnstone Biologics Corp. VERV 12.04 27.95% Verve Therapeutics, Inc. KTRA 0.76 79.68% Kintara Therapeutics, Inc. SRPT 67.31 37.47% Sarepta Therapeutics, Inc. MSS 5.60 30.95% Maison Solutions Inc. Class A Last updated October 31 at 4:00 PM ET Have feedback? We'd love to hear from you. Send your questions and feedback to marketsnow@cnn.com MARKETS NOW You are receiving this email because you signed up for updates from Markets Now.   No longer want to receive these updates? Unsubscribe. Interested in more? See all of our newsletters.   Create CNN Account | Listen to CNN Audio | Download the CNN App    ® © 2023 Cable News Network, Inc. A Warner Bros. Discovery Company. All Rights Reserved. One CNN Center Atlanta, GA 30303